MacuLogix Inc.
http://www.maculogix.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MacuLogix Inc.
Medtech Execs On The Move, May 2014
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Start-Up Execs On The Move, May 2014
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
MacuLogix Inc.
The AdaptDx from MacuLogix Inc. has the potential to be the first practical diagnostic instrument for early detection of AMD. Akin to routine peripheral vision testing for glaucoma, the noninvasive desktop device measures impaired dark adaptation (the speed with which vision is recovered when moving from a brightly lit environment to darkness), an early-stage marker of AMD development.
MacuLogix Inc.
The AdaptDx from MacuLogix Inc. has the potential to be the first practical diagnostic instrument for early detection of AMD. Akin to routine peripheral vision testing for glaucoma, the noninvasive desktop device measures impaired dark adaptation (the speed with which vision is recovered when moving from a brightly lit environment to darkness), an early-stage marker of AMD development.
Company Information
- Industry
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Equipment & Supplies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice